Cart
sales@molnova.com
Rhoifolin
CAS No. 17306-46-6
Rhoifolin ( —— )
Catalog No. M18121 CAS No. 17306-46-6
Rhoifolin is extracted from Turpinia arguya Seem dried leaves.
Purity : 98%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 49 | In Stock |
|
| 10MG | 88 | In Stock |
|
| 25MG | 157 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameRhoifolin
-
NoteResearch use only, not for human use.
-
Brief DescriptionRhoifolin is extracted from Turpinia arguya Seem dried leaves.
-
DescriptionRhoifolin is extracted from Turpinia arguya Seem dried leaves.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research AreaOthers-Field
-
Indication——
Chemical Information
-
CAS Number17306-46-6
-
Formula Weight578.53
-
Molecular FormulaC27H30O14
-
Purity98%
-
Solubility——
-
SMILESc1(cc(=O)c2c(cc(cc2o1)O[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O[C@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)C)O)O)O)O)c1ccc(cc1)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Rao YK, et al. Evid Based Complement Alternat Med. 2011;2011:624375.
molnova catalog
related products
-
3-Chloro-L-Tyrosine
3-Chlorotyrosine a specific marker of myeloperoxidase-catalyzed oxidation is markedly elevated in low-density lipoprotein isolated from human atherosclerotic intima. In particular myeloperoxidase halogenates tyrosine residues in plasma proteins and generates 3-chlorotyrosine (CY).
-
Acetrizoic acid
Acetrizoic acid is a molecule used as a contrast medium.
-
PIN1 inhibitor API-1
PIN1 inhibitor API-1 is a specific Pin1 inhibitor (IC50: 72.3 nM). PIN1 inhibitor API-1 retains the active conformation of pXPO5 and restores the ability of pXPO5 to transport pre-miRNAs from the nucleus to cytoplasm, thus up-regulating the anticancer miRNA biogenesis to suppress both in vitro and in vivo hepatocellular carcinoma development.
